Skin trauma
Conditions
Interventions
Group 1:Erythromycin ointment + RhTWEAK gel
Group 2:Erythromycin ointment + matrix gel
Group 3:Erythromycin ointment + recombinant human epidermal growth factor gel
Group 4:Erythromycin ointment
Sponsors
The Second Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Male or female patients aged 18 to 75 years old; (2) There are at least 4 pigmented nevi located at the face, chest or back or limb symmetry, which are suitable for laser treatment; (3) The patients sign the informed consent form before this clinical trial.
Exclusion criteria
Exclusion criteria: (1) The patients suffer from other skin diseases such as eczema and psoriasis or mental illness; (2) The patients have suspected or indeed a history of alcohol or drug abuse; (3) The patients have other diseases such as malignant tumors, vascular abnormalities, immunodeficiency, diabetes, severe kidney disease, etc., which may cause delayed wound healing; (4) The patients are using drugs that affect wound healing such as chemotherapy and immunosuppressive agents; (5) The pregnant women and lactating women; (6) The patients have allergic history (allergic to two or more drugs, food and pollen) are allergic to the pharmaceutical ingredients (carbomer 940, triethanolamine, p-hydroxybenzylamine ethyl ester and ethanol); (7) The patients are suffering from severe or uncontrolled local or systemic acute or chronic infections; (8) The patients are believed by the investigators not suitable for participating in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Beauty effect; | — |
Countries
China
Contacts
Public ContactYumin Xia
The Second Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed